| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2 | 22 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 5.079 | 680 | 724 | 238 | 7.936 | 1.160 | 593 | 342 | 316 | 287 |
| Gross Profit/Loss - EUR | -5.077 | -658 | -716 | -238 | -7.936 | -1.160 | -593 | -342 | -316 | -287 |
| Net Profit/Loss - EUR | -5.077 | -658 | -716 | -238 | -7.936 | -1.160 | -593 | -342 | -316 | -287 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Medspa Group Europe S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 733 | 426 | 144 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 1.111 | 110 | 23 | 83 | 268 | 273 | 109 | 38 | 11 | -693 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 60 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 1.111 | 49 | 23 | 83 | 268 | 273 | 109 | 38 | 11 | -693 |
| Shareholders Funds | -5.351 | -5.955 | -6.570 | -6.688 | -11.334 | -12.278 | -12.599 | -12.981 | -13.258 | -13.471 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 5.268 | 5.168 | 5.054 | 5.069 | 5.054 | 5.026 |
| Debts | 7.195 | 6.490 | 6.736 | 6.771 | 11.951 | 12.894 | 13.043 | 13.355 | 13.603 | 13.111 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7912 - 7912" | |||||||||
| CAEN Financial Year |
7912
|
|||||||||
Comments - Medspa Group Europe S.r.l.